Clinical Trial Update: Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Tumors and Metastatic Bone Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating time associated with preparation and administration of denosumab and pamidronate in patients with solid tumors and metastatic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Disease
• Solid Tumor

Drugs mentioned

• Denosumab (denosumab)
• Pamidronate disodium (Pamidronate disodium)

Snippet

Sponsor: Amgen | Conditions: Solid Tumor, Metastatic Bone Disease | Phase 4 | Status: WITHDRAWN